People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. | — | Pharma | Series A | $10.2M | $10.9M | 2024 |
Mary J. Fisher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mary J. Fisher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven J. Mento | 1 | 2 |
| Gerald Proehl | 1 | 2 |
| Wendell J. Wierenga | 1 | 2 |
| Andrew J. Sandler | 1 | 1 |
| Kyri K. Van Hoose | 1 | 1 |
| David J. Hale | 1 | 1 |
| Christopher J. Nardo | 1 | 1 |
| Brittany J. Bradrick | 1 | 1 |
| Maria J. Bedoya Toro Munera | 1 | 1 |
| Kathleen J. Scott | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.